Suchergebnisse - "Chan, Stephen L"

PubPharm (240)

1

Organ-specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma : A multicentre, retrospective study

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Cheon, J. | Jung, S. | Kim, J. | +8

2

Recent Advances in Systemic Therapy for Advanced Intrahepatic Cholangiocarcinoma

enthalten in: Liver cancer | 2024

von Yoo, C. | Hyung, J. | Chan, S.

3

A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma

enthalten in: JHEP reports : innovation in hepatology | 2024

von Santoro, A. | Assenat, E. | Yau, T. | +12

4

Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment

enthalten in: Journal of hepatology | 2024

von Chan, S. | Ryoo, B. | Mo, F. | +7

5

Genomic origin, fragmentomics, and transcriptional properties of long cell-free DNA molecules in human plasma

enthalten in: Genome research | 2024

von Che, H. | Jiang, P. | Choy, L. | +15

6

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312) : final results of a randomised phase 3 study

enthalten in: The lancet. Gastroenterology & hepatology | 2024

von Yau, T. | Kaseb, A. | Cheng, A. | +19

7

Dual CTLA-4 and PD-1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors : A first-in-human, dose-escalation, and dose-expansion study

enthalten in: Cancer | 2024

von Bishnoi, S. | Kotasek, D. | Aghmesheh, M. | +14

8

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Sangro, B. | Chan, S. | Kelley, R. | +123

9

Radiotherapy following intrahepatic progression on immunotherapy in advanced hepatocellular carcinoma

enthalten in: Journal of hepatology | 2024

von Chan, L. | Mok, K. | Chan, S.

10

Plain language summary of the HIMALAYA study : tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer)

enthalten in: Future oncology (London, England) | 2023

von Abou-Alfa, G. | Lau, G. | Kudo, M. | +27

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]